Source-faithful Form 13F holdings

Inspect one exact 13F filing without inventing company positions.

Enter a 13F-HR or 13F-HR/A accession. Issuer names, CUSIPs, manager identity, values, amounts, discretion, and voting authority remain filing observations.

Exact filing

This page

One explicit accession. No automatic amendment merge, manager canonicalization, or issuer/company resolution.

Company-centric

Current admitted ownership is separate

For reviewed current Section 16 and Schedule 13 subsets, query the canonical company ownership endpoint instead.

Open company ownership →
Clear
13F-HRReport period 2026-06-30

Paradigm Biocapital Advisors LP

Manager observed CIK 0001855655Filed 2026-08-14Open filing detail →
Filing observations, not canonical company/security identities

The manager name is observed from the filing header, issuer names are reported labels, CUSIP is not promoted into canonical security identity, and the API applies no company resolution to these rows.

yesexact accession scoped
noautomatic amendment merge
nomanager canonicalized
nocompany resolution applied

Information-table rows

28 reported holdings

Showing 26–28
Values reported in thousands USD
#25

VAXCYTE INC

COM

CUSIP 92243G108
Reported value
123692037 × $1,000
Reported amount
2127852 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
2127852
Shared
0
None
0
#26

VIRIDIAN THERAPEUTICS INC

COM

CUSIP 92790C104
Reported value
123515986 × $1,000
Reported amount
6723788 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
6723788
Shared
0
None
0
#27

VOR BIOPHARMA INC

COM NEW

CUSIP 929033207
Reported value
32217500 × $1,000
Reported amount
1750000 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
1750000
Shared
0
None
0
API version sec-api-v1Authority sec-13f-institutional-holdings-v1Manager identity sec-filing-header-observationRequest-time SEC fetch no